Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 3, 2009, Pages 1061-1066

  Starks, Angela M ^a   Gumusboga, Aysel ^a,c   Plikaytis, Bonnie B ^a   Shinnick, Thomas M ^a   Posey, James E ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b M/S F08 ^*  (United States)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL;

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CODON; CONTROLLED STUDY; EMBB GENE; GENE FUNCTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANTITUBERCULAR AGENTS; CODON; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION;

EID: 62949172213     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01357-08     Document Type: Article

References (37)

1. Ahmad, S., A. A. Jaber, and E. Mokaddas. 2007. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinburgh) 87:123-129.
2. Ahmad, S., E. Mokaddas, and A. A. Jaber. 2004. Rapid detection of etham butol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. Mol. Cell. Probes 18:299-306.
3. Alcaide, F., G. E. Pfyffer, and A. Telenti. 1997. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob. Agents Chemother. 41:2270-2273.
4. Bardarov, S., S. Bardarov, Jr., M. S. Pavelka, Jr., V. Sambandamurthy, M. Larsen, J. Tufariello, J. Chan, G. Hatfull, and W. R. Jacobs, Jr. 2002. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148:3007-3017.
5. Belanger, A. E., G. S. Besra, M. E. Ford, K. Mikusova, J. T. Belisle, P. J. Brennan, and J. M. Inamine. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA 93:11919-11924.
6. Braunstein, M., S. S. Bardarov, and W. R. Jacobs, Jr. 2002. Genetic methods for deciphering virulence determinants of Mycobacterium tuberculosis. Methods Enzymol. 358:67-99.
7. Brewer, T. F., and S. J. Heymann. 2005. Long time due: reducing tuberculosis mortality in the 21st century. Arch. Med. Res. 36:617-621.
8. Gangadharam, P. R., P. F. Pratt, V. K. Perumal, and M. D. Iseman. 1990. The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 141:1478-1482.
9. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
10. Hazbon, M. H., M, Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Bill man-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M, Bose, F. Chaves, K. D. Eisenach, J, Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802.
11. Isola, D-, M. Pardini, F. Varaine, S. Niemann, S. Rusch-Gerdes, L. Fattorini, G. Orefici, F. Meacci, C. Trappetti, M. Rinaldo Oggioni, the LONG-DRUG Study Group, and G. Orru. 2005. A pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J. Microbiol. Methods. 62:113-120.
12. Johnson, R., A. M. Jordaan, L. Pretorius, E. Engelke, G. van der Spuy, C. Kewley, M. Bosman, P. D. van Helden, R. Warren, and T. C. Victor. 2006. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis. 10:68-73.
13. Johnson, R., E. M. Streicher, G. E. Louw, R. M. Warren, P. D. van Helden, and T. C. Victor. 2006. Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 8:97-111.
14. Lee, A. S., S. N. Othman, Y. M. Ho, and S. Y. Wong. 2004. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:4447-4449.
15. Luria, S. E., and M. Delbruck. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
16. Madison, B., B. Robinson-Dunn, I. George, W. Gross, H. Lipman, B. Met-chock, A. Sloutsky, G. Washabaugh, G. Mazurek, and J. Ridderhof. 2002. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J. Clin. Microbiol. 40:3976-3979.
17. Miller, L. P., J. T. Crawford, and T. M. Shinnick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
18. Mokrousov, I., O. Narvskaya, E. Limeschenko, T. Otten, and B. Vyshnevskiy. 2002. Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting embB 306 mutations. J. Clin. Microbiol. 40:1617-1620.
19. Mokrousov, L, T. Otten, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of embB 306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40:3810-3813.
20. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
21. Parsons, L. M., M. Salfinger, A. Clobridge, J. Dormandy, L. Mirabello, V. L. Polletta, A. Sank, O. Sinyavskiy, S. C. Larsen, J. Driscoll, G. Zickas, and H. W. Taber. 2005. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob. Agents Chemother. 49:2218-2225.
22. Plikaytis, B. B., R. H. Gelber, and T. M. Shinnick. 1990. Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. J. Clin. Microbiol. 28:1913-1917.
23. Plinke, C, S. Rusch-Gerdes, and S. Niemann. 2006. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 50:1900-1902.
24. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
25. Ramaswamy, S. V., A. G. Amin, S. Goksel, C. E. Stager, S. J. Dou, H. El Sahly, S. L. Moghazeh, B. N. Kreiswirth, and J. M. Musser. 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:326-336.
26. Rinder, H-, K. T. Mieskes, E. Tortoli, E. Richter, M. Casal, M. Vaquero, E. Cambau, K. Feldmann, and T. Loscher. 2001. Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. Mol. Cell. Probes 15:37-42.
27. Safi, H., B. Sayers, M. H. Hazbon, and D. Alland. 2008. Transfer of embB 306 mutations into clinical Mycobacterium tuberculosis alters susceptibility to ethambutol. isoniazid, and rifampin. Antimicrob. Agents Chemother. 52: 2027-2034.
28. Shah, N. S., A. Wright, G. H. Bai, L. Barrera, F. Boulahbal, N. Martin-Casabona, F. Drobniewski, C. Gilpin, M. Havelkova, R. Lepe, R. Lumb, B. Metehoek, F. Portaels, M. F. Rodrigues, S. Rusch-Gerdes, A. Van Deun, V. Vincent, K. Laserson, C. Wells, and J. P. Cegielski. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13:380-387.
29. Sharma, S. K., and A. Mohan. 2006. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:261-272.
30. Shen, X., G. M. Shen, J. Wu, X. H. Gui, X. Li, J. Mei, K. DeRiemer, and Q. Gao. 2007. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 2618-2620.
31. Shi, R., J. Zhang, K. Otomo, G. Zhang, and I. Sugawara. 2007. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Antimicrob. Agents Chemother. 51:4515-4517.
32. Sreevatsan, S-, K. E. Stockbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazeh, W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681.
33. Takayama, K., and J. O. Kilburn. 1989. Inhibition of synthesis of arabinoga-lactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother.'33:1493-1499.
34. Telenti, A., W. J. Philipp, S. Sreevatsan, C. Bernasconi, K. E. Stockbauer, B. Wieles, J. M. Musser, and W. R. Jacobs, Jr. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3:567-570.
35. Tracevska, T., I. Jansone, A. Nodieva, O. Marga, G. Skenders, and V. Baumanis. 2004. Characterisation of rpsL, its and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res. Microbiol. 155:830-834.
36. Victor, T. C, A. M. Jordaan, A. van Rie, G. D. van der Spuy, M. Richardson, P. D. van Helden, and R. Warren. 1999. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber. Lung Dis. 79:343-348.
37. Vilcheze, C, F. Wang, M. Arai, M. H. Hazbon, R. Colangeli, L. Kremer, T. R. Weisbrod, D. Alland, J. C. Sacchettini, and W. R. Jacobs, Jr. 2006. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med. 12:1027-1029.